Substance-related Disorders Clinical Trials
3 recruiting trials for Substance-related Disorders. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Substance-related Disorders clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by VA Office of Research and Development (1), Clínica Nuestra Señora de la Paz (1), University of Maryland, College Park (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Combined Recovery Program (behavioral, 1 trial), followed by Stable & Able (S&A), Standard Multidisciplinary Treatment.
Track Substance-related Disorders trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
CRP and S&A for Inpatient Veterans
The purpose of this study is to evaluate how well three types of treatments work to improve the outcomes for people with substance use problems. Veterans admitted to the...
Prevention of Relapse in Behavioral Disorders
This study aims to validate the effectiveness of a digital tool for monitoring and early relapse detection in addiction treatment. It compares outcomes between a traditional...
Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention
The purpose of this study is to evaluate the feasibility and effectiveness of a peer-led, brief, behavioral intervention to improve adherence to medication for opioid use disorder...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Substance-related Disorders, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Substance-related Disorders, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Substance-related Disorders, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.